8-K/A

CURRENT REPORT

Company: Actinium Pharmaceuticals, Inc.
Filed: January 28, 2013
Period of Report: December 28, 2012
Accession Number: 0001213900-13-000373

View Document ↗ View on SEC.gov ↗